Opko Health (OPK) EBIT: 2010-2025
Historic EBIT for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $48.1 million.
- Opko Health's EBIT rose 238.04% to $48.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$112.2 million, marking a year-over-year increase of 40.29%. This contributed to the annual value of -$152.1 million for FY2024, which is 3.16% up from last year.
- Latest data reveals that Opko Health reported EBIT of $48.1 million as of Q3 2025, which was up 180.12% from -$60.0 million recorded in Q2 2025.
- Opko Health's EBIT's 5-year high stood at $48.1 million during Q3 2025, with a 5-year trough of -$87.8 million in Q3 2022.
- Moreover, its 3-year median value for EBIT was -$60.0 million (2025), whereas its average is -$35.3 million.
- Its EBIT has fluctuated over the past 5 years, first tumbled by 977.86% in 2024, then surged by 238.04% in 2025.
- Quarterly analysis of 5 years shows Opko Health's EBIT stood at -$63.1 million in 2021, then rose by 12.39% to -$55.3 million in 2022, then declined by 24.93% to -$69.0 million in 2023, then skyrocketed by 52.00% to -$33.1 million in 2024, then skyrocketed by 238.04% to $48.1 million in 2025.
- Its EBIT was $48.1 million in Q3 2025, compared to -$60.0 million in Q2 2025 and -$67.2 million in Q1 2025.